| Report Title | Price | Action |
|---|---|---|
| Cells Expressing Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021
Cells Expressing Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Drugs in Development, 2021 Summary Cells Expressing Programmed ...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021
NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021 Summary NADPH Oxidase (NOX or EC 1.6.3.1) - Drugs in Development, 2021 provides in de...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Beta Tubulin (TUBB) - Drugs in Development, 2021
Beta Tubulin (TUBB) - Drugs in Development, 2021 Summary Beta Tubulin (TUBB) - Drugs in Development, 2021 provides in depth analysis on Beta Tubulin...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Conjunctivitis (Ophthalmology) - Drugs in Development, 2021
Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 Summary Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021
Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021 Summary Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 70
|
$ 2000 | |
| Interleukin 2 Receptor Subunit Beta (High Affinity IL 2 Receptor Subunit Beta or Interleukin 15 Receptor Subunit Beta or p70-75 or CD122 or IL2RB) - Drugs in Development, 2021
Interleukin 2 Receptor Subunit Beta (High Affinity IL 2 Receptor Subunit Beta or Interleukin 15 Receptor Subunit Beta or p70-75 or CD122 or IL2RB) - D...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Protein Kinase C (PKC or PRKC or EC 2.7.11.13) - Drugs in Development, 2021
Protein Kinase C (PKC or PRKC or EC 2.7.11.13) - Drugs in Development, 2021 Summary Protein Kinase C (PKC or PRKC or EC 2.7.11.13) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| C-C Chemokine Receptor Type 8 (CC Chemokine Receptor CHEMR1 or CMKBRL2 or Chemokine Receptor Like 1 or GPR CY6 or TER1 or CDw198 or CCR8) - Drugs in Development, 2021
C-C Chemokine Receptor Type 8 (CC Chemokine Receptor CHEMR1 or CMKBRL2 or Chemokine Receptor Like 1 or GPR CY6 or TER1 or CDw198 or CCR8) - Drugs in D...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021
Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021 Summary Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Interleukin 6 Receptor (IL6R) - Drugs in Development, 2021
Interleukin 6 Receptor (IL6R) - Drugs in Development, 2021 Summary Interleukin 6 Receptor (IL6R) - Drugs in Development, 2021 provides in depth anal...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Ras (EC 3.6.5.2) - Drugs in Development, 2021
Ras (EC 3.6.5.2) - Drugs in Development, 2021 Summary Ras (EC 3.6.5.2) - Drugs in Development, 2021 provides in depth analysis on Ras (EC 3.6.5.2) t...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6 or CDw199 or CCR9) - Drugs in Development, 2021
C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6 or CDw199 or CCR9) - Drugs in Development, 2021 Summary C-C Chemokine Recept...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs in Development, 2021
Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs in Development, 2021 Summary Multiple Organ Failure (Multiple ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| NACHT LRR And PYD Domains Containing Protein 3 (Caterpiller Protein 1.1 or Cold Autoinflammatory Syndrome 1 Protein or Cryopyrin or Nucleotide Binding Oligomerization Domain Leucine Rich Repeat And Pyrin Domain Containing 3 or NLRP3) - Drugs in Development, 2021
NACHT LRR And PYD Domains Containing Protein 3 (Caterpiller Protein 1.1 or Cold Autoinflammatory Syndrome 1 Protein or Cryopyrin or Nucleotide Binding...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Receptor Interacting Serine/Threonine Protein Kinase 1 (Cell Death Protein RIP or Receptor Interacting Protein 1 or Serine/Threonine Protein Kinase RIP or RIP1 or RIPK1 or EC 2.7.11.1) - Drugs in Development, 2021
Receptor Interacting Serine/Threonine Protein Kinase 1 (Cell Death Protein RIP or Receptor Interacting Protein 1 or Serine/Threonine Protein Kinase RI...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) - Drugs in Development, 2021
Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) - Drugs in Development, 2021 Summary Calcium Activated Neutral Protease (...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Pulmonary Radiation Toxicity (Toxicology) - Drugs in Development, 2021
Pulmonary Radiation Toxicity (Toxicology) - Drugs in Development, 2021 Summary Pulmonary Radiation Toxicity (Toxicology) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) - Drugs in Development, 2021
NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) - Drugs in Development, 2021 Summary NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Xanthine Dehydrogenase/Oxidase (Xanthine Dehydrogenase or Xanthine Oxidase or Xanthine Oxidoreductase or XDH or EC 1.17.1.4 or EC 1.17.3.2) - Drugs in Development, 2021
Xanthine Dehydrogenase/Oxidase (Xanthine Dehydrogenase or Xanthine Oxidase or Xanthine Oxidoreductase or XDH or EC 1.17.1.4 or EC 1.17.3.2) - Drugs in...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| cAMP Specific 3',5' Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B or EC 3.1.4.53) - Drugs in Development, 2021
cAMP Specific 3',5' Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B or EC 3.1.4.53) - Drugs in Development, 2021 Summary cAMP Specific 3',5' Cy...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 |